{"protocolSection": {"identificationModule": {"nctId": "NCT01219738", "orgStudyIdInfo": {"id": "20071068"}, "secondaryIdInfos": [{"id": "IRUSBUPF0002", "type": "OTHER", "domain": "Sponsor"}], "organization": {"fullName": "University of Miami", "class": "OTHER"}, "briefTitle": "Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide", "officialTitle": "Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide"}, "statusModule": {"statusVerifiedDate": "2015-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2008-07"}, "primaryCompletionDateStruct": {"date": "2012-08", "type": "ACTUAL"}, "completionDateStruct": {"date": "2012-08", "type": "ACTUAL"}, "studyFirstSubmitDate": "2010-10-12", "studyFirstSubmitQcDate": "2010-10-12", "studyFirstPostDateStruct": {"date": "2010-10-13", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2014-11-12", "resultsFirstSubmitQcDate": "2015-01-07", "resultsFirstPostDateStruct": {"date": "2015-01-16", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-01-07", "lastUpdatePostDateStruct": {"date": "2015-01-16", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "PRINCIPAL_INVESTIGATOR", "investigatorFullName": "Eliana Mendes", "investigatorTitle": "University of Miami", "investigatorAffiliation": "University of Miami"}, "leadSponsor": {"name": "University of Miami", "class": "OTHER"}, "collaborators": [{"name": "AstraZeneca", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Glucocorticosteroids recently have been shown to have non-genomic actions that are plasma membrane-mediated and do not require gene transcription and translation. One of these non-genomic effects is the inhibition of adrenergic agonist transport into airway vascular smooth muscle cells with an increase of adrenergic agonist concentrations at adrenergic receptor sites and enhance the physiological effects of endogenous adrenergic agonists (e.g. locally released norepinephrine from noradrenergic neurons) or exogenous adrenergic agonists (e.g. inhaled beta-adrenergic agonists).", "detailedDescription": "Inhaled glucocorticosteroids typically are not recommended for the treatment of acute asthma attacks. This practice is based on the fact that glucocorticosteroids by themselves do not cause rapid bronchodilation. However, the acute inhibition of adrenergic agonist disposal by the non-genomic action of glucocorticosteroids could lead to bronchial vasoconstriction by locally released norepinephrine thereby decongesting the airway wall, and potentiate the bronchodilator effect of a concomitantly administered beta-adrenergic agonist through the same mechanism. The purpose of this study is to assess the vasoconstrictive effects of single and repetitive high-dose budesonide inhalations in moderate to severe asthmatics who use inhaled glucocorticosteroids regularly. As a secondary endpoint, airway inflammation and airway function will also be measured with the expectation that acute improvements in airflow might be detectable as a result of airway decongestion, notably in subjects with moderately severe asthma who have lower baseline lung function."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma, airway blood flow, budesonide, glucocorticosteroid."]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "BASIC_SCIENCE", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 20, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "budesonide 360ug", "type": "EXPERIMENTAL", "description": "asthmatic subject received different doses of inhaled budesonide in random other", "interventionNames": ["Drug: Budesonide 360ug"]}, {"label": "budesonide 720ug", "type": "EXPERIMENTAL", "description": "asthmatic subject received different doses of inhaled budesonide in random other", "interventionNames": ["Drug: Budesonide 720ug"]}, {"label": "budesonide 1440ug", "type": "EXPERIMENTAL", "description": "asthmatic subject received different doses of inhaled budesonide in random other", "interventionNames": ["Drug: Budesonide 1440ug"]}, {"label": "placebo", "type": "PLACEBO_COMPARATOR", "description": "asthmatic subject received inhaled placebo", "interventionNames": ["Drug: Budesonide720ug 4 times"]}, {"label": "Budesonide720ug 4 times", "type": "EXPERIMENTAL", "description": "asthmatic subject received 720ug of inhaled budesonide 4 times separated by 30 minutes.", "interventionNames": ["Drug: Placebo"]}], "interventions": [{"type": "DRUG", "name": "Budesonide 360ug", "description": "A single inhaled dose of 360ug budesonide from a DPI.", "armGroupLabels": ["budesonide 360ug"], "otherNames": ["Pulmicort Flexhaler"]}, {"type": "DRUG", "name": "Budesonide 720ug", "description": "A single inhaled dose of 720ug budesonide from a DPI.", "armGroupLabels": ["budesonide 720ug"], "otherNames": ["Pulmicort Flexhaler"]}, {"type": "DRUG", "name": "Budesonide 1440ug", "description": "A single dose of 1440ug of the budesonide from DPI.", "armGroupLabels": ["budesonide 1440ug"], "otherNames": ["Pulmicort Flexhaler"]}, {"type": "DRUG", "name": "Budesonide720ug 4 times", "description": "720ug of budesonide will be inhaled by the subjects 4 times, separated by 30 minutes.", "armGroupLabels": ["placebo"], "otherNames": ["Pulmicort Flexhaler"]}, {"type": "DRUG", "name": "Placebo", "description": "A single inhaled dose of placebo from a DPI.", "armGroupLabels": ["Budesonide720ug 4 times"], "otherNames": ["sugar pill"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Airway Blood Flow (Qaw)", "description": "Qaw will be measured before and up to 6 hours after a single inhaled dose of 360ug, 720ug, and 1440ug budesonide or placebo from a DPI, using a double-blinded randomized design on different days.", "timeFrame": "participants will be followed for 6 hours after budesonide dose"}], "secondaryOutcomes": [{"measure": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "FEV1 will be measured before and up to 6 hours after a single inhaled dose of 360ug, 720ug, and 1440ug budesonide or placebo from a DPI, using a double-blinded randomized design on different days.", "timeFrame": "participant will be followed up to 6 hours after budesonide dose"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\nTwenty lifetime nonsmokers moderate or severe asthmatics; FEV1\u226550 of predicted on the screening day\n\nExclusion Criteria:\n\nWomen of childbearing potential who do not use accepted birth control measures; pregnant and breast feeding women; Cardiovascular disease and/or use of cardiovascular medication; Subjects with known beta-adrenergic agonist or glucocorticosteroid intolerance; Acute respiratory infection and or acute exacerbation of asthma within four weeks prior to the study; Use of systemic glucocorticosteroids within 4 weeks prior to the study; Daily ICS dose (fluticasone or budesonide) \\> 500ug; Diabetes mellitus", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "65 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Eliana Mendes, MD", "affiliation": "University of Miami", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Pulmonary Human Research Laboratory, University of Miami, Miller School of Medicine", "city": "Miami", "state": "Florida", "zip": "33136", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}]}, "referencesModule": {"references": [{"pmid": "12807698", "type": "BACKGROUND", "citation": "Horvath G, Sutto Z, Torbati A, Conner GE, Salathe M, Wanner A. Norepinephrine transport by the extraneuronal monoamine transporter in human bronchial arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2003 Oct;285(4):L829-37. doi: 10.1152/ajplung.00054.2003. Epub 2003 Jun 13."}, {"pmid": "11694456", "type": "BACKGROUND", "citation": "Horvath G, Lieb T, Conner GE, Salathe M, Wanner A. Steroid sensitivity of norepinephrine uptake by human bronchial arterial and rabbit aortic smooth muscle cells. Am J Respir Cell Mol Biol. 2001 Oct;25(4):500-6. doi: 10.1165/ajrcmb.25.4.4559."}, {"pmid": "12797493", "type": "BACKGROUND", "citation": "Mendes ES, Pereira A, Danta I, Duncan RC, Wanner A. Comparative bronchial vasoconstrictive efficacy of inhaled glucocorticosteroids. Eur Respir J. 2003 Jun;21(6):989-93. doi: 10.1183/09031936.03.00072402."}, {"pmid": "10619834", "type": "BACKGROUND", "citation": "Brieva JL, Danta I, Wanner A. Effect of an inhaled glucocorticosteroid on airway mucosal blood flow in mild asthma. Am J Respir Crit Care Med. 2000 Jan;161(1):293-6. doi: 10.1164/ajrccm.161.1.9905068."}, {"pmid": "24735128", "type": "DERIVED", "citation": "Mendes ES, Rebolledo P, Campos M, Wanner A. Immediate antiinflammatory effects of inhaled budesonide in patients with asthma. Ann Am Thorac Soc. 2014 Jun;11(5):706-11. doi: 10.1513/AnnalsATS.201307-220OC."}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "All Study Participants", "description": "asthmatic subject received different doses of inhaled budesonide\n\nBudesonide: A single inhaled dose of 360ug budesonide from a DPI.\n\nBudesonide: A single inhaled dose of 720ug budesonide from a DPI.\n\nBudesonide: A single dose of 1440ug of the budesonide from DPI.\n\nBudesonide: 720ug of budesonide will be inhaled by the subjects 4 times, separated by 30 minutes.\n\nPlacebo: A single inhaled dose of placebo from a DPI."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "Budesonide 360", "achievements": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "Budesonide 720", "achievements": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "Budesonide 1440", "achievements": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "Budesonide 720- 4 Times", "achievements": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Asthma", "description": "asthmatic subject received different doses of inhaled budesonide\n\nBudesonide: A single inhaled dose of 360ug budesonide from a DPI.\n\nBudesonide: A single inhaled dose of 720ug budesonide from a DPI.\n\nBudesonide: A single dose of 1440ug of the budesonide from DPI.\n\nBudesonide: 720ug of budesonide will be inhaled by the subjects 4 times, separated by 30 minutes.\n\nPlacebo: A single inhaled dose of placebo from a DPI."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "20"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "43", "lowerLimit": "22", "upperLimit": "66"}]}]}]}, {"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "19"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "1"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "12"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "8"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "20"}]}]}]}, {"title": "Airway blood flow", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "\u03bcl/min/ml", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "52.3", "spread": "3.5"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Airway Blood Flow (Qaw)", "description": "Qaw will be measured before and up to 6 hours after a single inhaled dose of 360ug, 720ug, and 1440ug budesonide or placebo from a DPI, using a double-blinded randomized design on different days.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of change from baseline", "timeFrame": "participants will be followed for 6 hours after budesonide dose", "groups": [{"id": "OG000", "title": "Budesonide 360ug", "description": "Budesonide: A single inhaled dose of 360ug budesonide from a DPI."}, {"id": "OG001", "title": "Budesonide 720ug", "description": "Budesonide: A single inhaled dose of 720ug budesonide from a DPI."}, {"id": "OG002", "title": "Budesonide 1440ug", "description": "Budesonide: A single dose of 1440ug of the budesonide from DPI."}, {"id": "OG003", "title": "Budesonide 720ug 4 Times", "description": "Budesonide: 720ug of budesonide will be inhaled by the subjects 4 times, separated by 30 minutes."}, {"id": "OG004", "title": "Placebo", "description": "Placebo: A single inhaled dose of placebo from a DPI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "20"}, {"groupId": "OG003", "value": "18"}, {"groupId": "OG004", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "22.3", "spread": "2.1"}, {"groupId": "OG001", "value": "29.4", "spread": "2.7"}, {"groupId": "OG002", "value": "34.1", "spread": "2.5"}, {"groupId": "OG003", "value": "28.2", "spread": "1.9"}, {"groupId": "OG004", "value": "5.1", "spread": "2.4"}]}]}]}, {"type": "SECONDARY", "title": "Forced Expiratory Volume in 1 Second (FEV1)", "description": "FEV1 will be measured before and up to 6 hours after a single inhaled dose of 360ug, 720ug, and 1440ug budesonide or placebo from a DPI, using a double-blinded randomized design on different days.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of change from baseline", "timeFrame": "participant will be followed up to 6 hours after budesonide dose", "groups": [{"id": "OG000", "title": "Budesonide 360 ug", "description": "Budesonide: A single inhaled dose of 360ug budesonide from a DPI."}, {"id": "OG001", "title": "Budesonide 720 ug", "description": "Budesonide: A single inhaled dose of 720ug budesonide from a DPI."}, {"id": "OG002", "title": "Budesonide 1440 ug", "description": "Budesonide: A single inhaled dose of 1440ug budesonide from a DPI."}, {"id": "OG003", "title": "720ug of Budesonide 4 Times", "description": "Budesonide: 720ug of budesonide will be inhaled by the subjects 4 times, separated by 30 minutes."}, {"id": "OG004", "title": "Placebo", "description": "A single inhaled dose of placebo from a DPI"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "20"}, {"groupId": "OG001", "value": "20"}, {"groupId": "OG002", "value": "20"}, {"groupId": "OG003", "value": "18"}, {"groupId": "OG004", "value": "20"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.6"}, {"groupId": "OG001", "value": "3.2", "spread": "1.9"}, {"groupId": "OG002", "value": "1.6", "spread": "1.8"}, {"groupId": "OG003", "value": "3.2", "spread": "2.4"}, {"groupId": "OG004", "value": "0.8", "spread": "2.8"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "overall study, up to six hour after each dose.", "eventGroups": [{"id": "EG000", "title": "All Study Participants", "description": "Budesonide:was given in different doses", "seriousNumAffected": 0, "seriousNumAtRisk": 20, "otherNumAffected": 0, "otherNumAtRisk": 20}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Eliana Mendes", "organization": "University of Miami", "email": "e.mendes@miami.edu", "phone": "(305) 243-2568"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "T170", "name": "Acute Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000019819", "term": "Budesonide"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}], "browseLeaves": [{"id": "M21711", "name": "Budesonide", "asFound": "Of 1", "relevance": "HIGH"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}